Goldstein, D.; Sahelijo, N.; Priyadarshi, D.; Panitch, R.; Nho, K.; Farrer, L.A.; Stein, T.D.; Jun, G.R.
Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease. J. Clin. Med. 2026, 15, 2885.
https://doi.org/10.3390/jcm15082885
AMA Style
Goldstein D, Sahelijo N, Priyadarshi D, Panitch R, Nho K, Farrer LA, Stein TD, Jun GR.
Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease. Journal of Clinical Medicine. 2026; 15(8):2885.
https://doi.org/10.3390/jcm15082885
Chicago/Turabian Style
Goldstein, Daniel, Nathan Sahelijo, Dhawal Priyadarshi, Rebecca Panitch, Kwangsik Nho, Lindsay A. Farrer, Thor D. Stein, and Gyungah R. Jun.
2026. "Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease" Journal of Clinical Medicine 15, no. 8: 2885.
https://doi.org/10.3390/jcm15082885
APA Style
Goldstein, D., Sahelijo, N., Priyadarshi, D., Panitch, R., Nho, K., Farrer, L. A., Stein, T. D., & Jun, G. R.
(2026). Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease. Journal of Clinical Medicine, 15(8), 2885.
https://doi.org/10.3390/jcm15082885
